Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris global luxury conglomerate (EPA: MC) at ~€84.7B 2024 revenue; 75+ brands (Louis Vuitton, Dior, Hennessy, Sephora), named preferred buyer for Giorgio Armani (€10B+) after founder's Sept 2025 death, competing with Kering and Hermès.
LVMH Moët Hennessy Louis Vuitton SE is a Paris, France-based global luxury goods conglomerate — publicly traded on Euronext Paris (EPA: MC) and the world's largest luxury company by revenue — owning and managing 75+ prestige brands across Fashion & Leather Goods, Wines & Spirits, Perfumes & Cosmetics, Watches & Jewelry, and Selective Retailing through approximately 213,000 employees serving luxury consumers across 6 continents. LVMH's flagship brands include Louis Vuitton (the world's most valuable luxury brand), Christian Dior Couture, Moët & Chandon, Dom Pérignon, Hennessy cognac, Givenchy, Celine, Fendi, Bulgari, TAG Heuer, Hublot, Sephora, and DFS. In fiscal year 2024, LVMH reported revenue of approximately €84.7 billion, with the Fashion & Leather Goods segment (Louis Vuitton and Dior, ~40% of revenue) demonstrating resilience in a challenging global luxury environment characterized by post-pandemic demand normalization, Chinese luxury consumer caution, and currency headwinds. CEO and Chairman Bernard Arnault — the world's wealthiest individual — has built LVMH through decades of acquisitions of trophy luxury brands. LVMH's most significant strategic development for 2025-2026 is the preferred buyer designation for Giorgio Armani following the Italian fashion designer's death in September 2025 — with LVMH named in Armani's will as the preferred acquirer of the €10B+ Armani Group, with an initial 15% purchase within 18 months potentially leading to a full acquisition of one of the world's last independent luxury fashion houses.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.